Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Press release – No. 13 / 2019 Zealand Pharma to attend Citi European Healthcare Conference Copenhagen, June 4, 2019 – Zealand Pharma Chief Executive Officer Emmanuel Dulac and Chief Medical and...
-
Company announcement – No. 18 / 2019 Total number of shares and voting rights in Zealand Pharma as of May 31, 2019 Copenhagen, June 3, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a...
-
Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...
-
Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...
-
Press release – No. 12 / 2019 Zealand Pharma to attend Jefferies and Goldman Sachs Global Healthcare Conferences Copenhagen, May 27, 2019 – Zealand Pharma Chief Executive Officer Emmanuel...
-
Press Release – No. 09 / 2019 Zealand Pharma hosts conference call on May 16 at 4 pm CET (10 am EST) to present first quarter results for 2019 Copenhagen, May 6, 2019 – Zealand Pharma A/S...
-
Company announcement – No. 14 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, April 17, 2019...
-
Press release – No. 08 / 2019 Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar Copenhagen, April 11, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the...
-
Company announcement – No. 13 / 2019 Zealand Pharma grants new warrants under employee warrant program Copenhagen, April 10, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50...
-
Press release – No. 07 / 2019 Zealand Pharma to attend Kempen Life Sciences Conference Copenhagen, April 08, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the Kempen Life...